Resources

For the latest in precision medicine, sign up for our monthly newsletter to be among the first to receive
exclusive insights, in-depth market analyses, and expert articles directly to your inbox

Biomarker Discovery & Development

Transforming Care for Cancer Patients

Single Cell Analysis

In Conversation With... Fan Zhang, Assistant Professor at the University of Colorado

Here, we speak to Fan Zhang, Assistant Professor at the University of Colorado, about the applications of computational biology in studying disease behaviour.
Single Cell Analysis

10x Genomics and Single Cell RNA Sequencing: Interview with Philip Bischoff and Angela Churchill

Unlocking the potential for FFPE samples in advancing single-cell sequencing for tumour microenvironment research.
Clinical Diagnostics

How AI is Opening New Doors in Synthetic Biology and Drug Design

Deep learning and AI are enhancing synthetic biology's role in drug design, emphasising the necessity of quality data in constructing models for approaches such as genome mining and data deconvolution.

Navigating the Pharma R&D Regulatory Landscape 2023

Our ‘Navigating the Regulatory Landscape’ eBook has been designed to provide you with invaluable insights into the intricacies of regulations & policies surrounding the challenges and opportunities of Real-World Data, genome editing, biomedical informatics, manufacturing and many more.
Single Cell Analysis

Integrating Machine Learning into Single-Cell Omics Analysis

Machine learning methods can be hugely important in aiding the interpretation and integration of data generated through single-cell omics analysis, assisting in disease detection and modelling.
Genomic Biomarkers

Applications of Spatial Transcriptome Technologies for Monitoring the Molecular Mechanisms of Diseases

Spatial transcriptomics leverages omics techniques to extract transcriptome data while retaining the context of the original tissue, aiding disease research, biomarker development, and understandings of tissue structures and cellular heterogeneity.
Genomic Biomarkers

How Multiplexing Could Increase the Availability of Blood Biomarkers for Classifying Neurodegenerative Disorders

Recent studies have used multiplex blood biomarker information from patients to distinguish individual patient subgroups for neurodegenerative diseases, helping to stratify patients by their pathology.

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things discovery